TWEAK/Fn14 Activation Participates in Skin Inflammation

Tumor necrosis factor- (TNF-) like weak inducer of apoptosis (TWEAK) participates in multiple biological activities via binding to its sole receptor—fibroblast growth factor-inducible 14 (Fn14). The TWEAK/Fn14 signaling pathway is activated in skin inflammation and modulates the inflammatory respons...

Full description

Saved in:
Bibliographic Details
Main Authors: Qilu Liu, Shengxiang Xiao, Yumin Xia
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/6746870
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695794747146240
author Qilu Liu
Shengxiang Xiao
Yumin Xia
author_facet Qilu Liu
Shengxiang Xiao
Yumin Xia
author_sort Qilu Liu
collection DOAJ
description Tumor necrosis factor- (TNF-) like weak inducer of apoptosis (TWEAK) participates in multiple biological activities via binding to its sole receptor—fibroblast growth factor-inducible 14 (Fn14). The TWEAK/Fn14 signaling pathway is activated in skin inflammation and modulates the inflammatory responses of keratinocytes by activating nuclear factor-κB signals and enhancing the production of several cytokines, including interleukins, monocyte chemotactic protein-1, RANTES (regulated on activation, normal T cell expressed and secreted), and interferon gamma-induced protein 10. Mild or transient TWEAK/Fn14 activation contributes to tissular repair and regeneration while excessive or persistent TWEAK/Fn14 signals may lead to severe inflammatory infiltration and tissue damage. TWEAK also regulates cell fate of keratinocytes, involving the function of Fn14-TNF receptor-associated factor-TNF receptor axis. By recruiting inflammatory cells, promoting cytokine production, and regulating cell fate, TWEAK/Fn14 activation plays a pivotal role in the pathogenesis of various skin disorders, such as psoriasis, atopic dermatitis, cutaneous vasculitis, human papillomavirus infection and related skin tumors, and cutaneous autoimmune diseases. Therefore, the TWEAK/Fn14 pathway may be a potential target for the development of novel therapeutics for skin inflammatory diseases.
format Article
id doaj-art-ce3e28e77a8c4c5281387dc747cb77ba
institution DOAJ
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-ce3e28e77a8c4c5281387dc747cb77ba2025-08-20T03:19:39ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/67468706746870TWEAK/Fn14 Activation Participates in Skin InflammationQilu Liu0Shengxiang Xiao1Yumin Xia2Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, ChinaDepartment of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, ChinaDepartment of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, ChinaTumor necrosis factor- (TNF-) like weak inducer of apoptosis (TWEAK) participates in multiple biological activities via binding to its sole receptor—fibroblast growth factor-inducible 14 (Fn14). The TWEAK/Fn14 signaling pathway is activated in skin inflammation and modulates the inflammatory responses of keratinocytes by activating nuclear factor-κB signals and enhancing the production of several cytokines, including interleukins, monocyte chemotactic protein-1, RANTES (regulated on activation, normal T cell expressed and secreted), and interferon gamma-induced protein 10. Mild or transient TWEAK/Fn14 activation contributes to tissular repair and regeneration while excessive or persistent TWEAK/Fn14 signals may lead to severe inflammatory infiltration and tissue damage. TWEAK also regulates cell fate of keratinocytes, involving the function of Fn14-TNF receptor-associated factor-TNF receptor axis. By recruiting inflammatory cells, promoting cytokine production, and regulating cell fate, TWEAK/Fn14 activation plays a pivotal role in the pathogenesis of various skin disorders, such as psoriasis, atopic dermatitis, cutaneous vasculitis, human papillomavirus infection and related skin tumors, and cutaneous autoimmune diseases. Therefore, the TWEAK/Fn14 pathway may be a potential target for the development of novel therapeutics for skin inflammatory diseases.http://dx.doi.org/10.1155/2017/6746870
spellingShingle Qilu Liu
Shengxiang Xiao
Yumin Xia
TWEAK/Fn14 Activation Participates in Skin Inflammation
Mediators of Inflammation
title TWEAK/Fn14 Activation Participates in Skin Inflammation
title_full TWEAK/Fn14 Activation Participates in Skin Inflammation
title_fullStr TWEAK/Fn14 Activation Participates in Skin Inflammation
title_full_unstemmed TWEAK/Fn14 Activation Participates in Skin Inflammation
title_short TWEAK/Fn14 Activation Participates in Skin Inflammation
title_sort tweak fn14 activation participates in skin inflammation
url http://dx.doi.org/10.1155/2017/6746870
work_keys_str_mv AT qiluliu tweakfn14activationparticipatesinskininflammation
AT shengxiangxiao tweakfn14activationparticipatesinskininflammation
AT yuminxia tweakfn14activationparticipatesinskininflammation